In the present study, the combination treatment with anti-PD-L1 antibody plus anti-VEGF antibody upregulated the expression levels of MHC class I molecules on tumor cells, which is another possible mechanism of immune enhancement, and also maintained the accumulation of CD8+ T cells in tumor tissues. This evidence concerns the gene CD8A and neoplasm.